Trupanion (TRUP)
(Delayed Data from NSDQ)
$53.50 USD
+2.61 (5.13%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.54 +0.04 (0.07%) 7:38 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.50 USD
+2.61 (5.13%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.54 +0.04 (0.07%) 7:38 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Zacks News
MetLife (MET) Launches Pet Insurance Product, Boosts Portfolio
by Zacks Equity Research
MetLife (MET) introduces a pet insurance product, which intends to offer enhanced care for pets and address financial stress of pet parents.
Moving Average Crossover Alert: Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -25.00% and 1.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Aflac's (AFL) first-quarter results are likely to reflect higher adjusted net investment income and cost-curbing efforts, partly offset by weaker sales.
Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -200.00% and 2.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -75.00% and 2.65%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 500.00% and 2.72%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Brown & Brown in Your Portfolio
by Zacks Equity Research
Brown & Brown (BRO) is poised to benefit from constant top-line growth and solid cash flow generating abilities.
Dull Near-Term Prospects for Accident & Health Insurance
by Tanuka De
Accident and Health Insurance industry should see new sales getting affected while frequency of claims from essential service industries are bound to rise.
Why Trupanion (TRUP) Might Surprise This Earnings Season
by Zacks Equity Research
Trupanion (TRUP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
by Zacks Equity Research
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
4 Top-Ranked Liquid Bets to Build a Successful Portfolio
by Zacks Equity Research
Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.
Trupanion (TRUP) Q4 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum (UNM) Rides on Premium Growth, Firm Financial Standing
by Zacks Equity Research
Unum (UNM) gains traction from strong contributions of its U.S. and International segments, investment in technology and solid liquidity.
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
4 Insurance Stocks for Your Investment Portfolio in 2020
by Zacks Equity Research
Rising insurance premium rates, solid capital position, changes to product portfolio and stable interest rate should drive insurance stocks in 2020.
Moving Average Crossover Alert: Trupanion
by Zacks Equity Research
Trupanion, Inc. (TRUP) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
MetLife to Foray Into Pet Insurance Via PetFirst Acquisition
by Zacks Equity Research
MetLife (MET) to acquire PetFirst to enter the rapidly growing pet insurance market.
Will Trupanion Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Trupanion.
Aflac Acquires Argus, Expands U.S. Segment Product Suite
by Zacks Equity Research
Aflac's (AFL) acquisition of Argus equips it to provide Dental and Vision products to customers in the United States.
Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 200.00% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.